Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
26.77
-0.38 (-1.40%)
At close: Dec 5, 2025, 4:00 PM EST
26.00
-0.77 (-2.88%)
After-hours: Dec 5, 2025, 6:34 PM EST
Amphastar Pharmaceuticals Employees
Amphastar Pharmaceuticals had 2,028 employees as of December 31, 2024. The number of employees increased by 267 or 15.16% compared to the previous year.
Employees
2,028
Change (1Y)
267
Growth (1Y)
15.16%
Revenue / Employee
$356,659
Profits / Employee
$55,044
Market Cap
1.23B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMPH News
- 11 days ago - Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference - Accesswire
- 23 days ago - Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - Accesswire
- 27 days ago - Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025 - Accesswire
- 5 weeks ago - Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025 - Accesswire
- 2 months ago - After Protracted Sell-Off, Amphastar Looks Like A Value Pick - Seeking Alpha
- 3 months ago - Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference - Accesswire
- 4 months ago - Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum - Benzinga